Status:
UNKNOWN
Risk Factors Worsening COVID19 for Out-patient With Home Monitoring
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Covid19
Eligibility:
All Genders
Brief Summary
The main objective of the COVIDADOMEVA study is to identify the risk factors aggravating the COVID-19 (risk or protective factors), in out-patients suspected of being infected with precocious home mon...
Detailed Description
In front of the recent emergence of the SARS-CoV-2 coronavirus (COVID) in December 2019 in the Wuhan region of China, knowledge of the clinical course and of the aggravating risk factors linked to thi...
Eligibility Criteria
Inclusion
- Patient with clinical symptomatology suspecting COVID-19, that is to say: severe dyspnea, and/or serious extra pulmonary signs (myalgia, diarrhea, etc.) OR
- Patient with clinical symptomatology (cough or dyspnea or fever with ENT signs) AND at least one of the following comorbidities: COPD stage 1 or 2 (dyspnea usually absent or for marked efforts), Asthma with daily inhaled corticosteroid therapy, Immunosuppression or cancer during chemotherapy, Coronary history, Heart failure (Stages 2 and 3, dyspnea with moderate or low effort), Obesity (BMI\> 30), Type 1 or 2 diabetes, cirrhosis from Child B, pregnant woman in the 3rd trimester.
- Patient with a phone monitoring of at least more than 2 calls, if no aggravation of disease.
Exclusion
- Person deprived of liberty by judicial or administrative decision
- Person being subject to a legal protection measure
- Person who expressed opposition to participating in the COVIDADOMEVA study
Key Trial Info
Start Date :
June 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT04380662
Start Date
June 30 2020
End Date
December 30 2020
Last Update
June 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grenoble University Hospital
Grenoble, France, 38000